Hoba Therapeutics ApS — Credit Rating and Financial Key Figures

Hoba Therapeutics ApS (CVR number: 38231170) is a company from KØBENHAVN. The company recorded a gross profit of -38348.4 kDKK in 2024. The operating profit was -48.7 mDKK, while net earnings were -43 mDKK. The profitability of the company measured by Return on Assets (ROA) was -68.7 %, which can be considered poor and Return on Equity (ROE) was -90.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 56.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Hoba Therapeutics ApS's liquidity measured by quick ratio was 5.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.